Condensed Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2019	Dec. 31, 2018
OPERATING EXPENSES
Amortization	$ 57,344	$ 57,344	$ 114,689	$ 114,689
Research and development expenses	346,514	206,019	688,015	400,540
Selling, general and administrative expenses	306,589	237,507	613,961	477,069
TOTAL OPERATING EXPENSES	710,447	500,870	1,416,665	992,298
LOSS FROM OPERATIONS	(710,447)	(500,870)	(1,416,665)	(992,298)
OTHER EXPENSE (INCOME)
Change in fair value of derivative liabilities	(7,396,192)		(7,758,778)
Gain on settlement of debt				(51,400)
Interest Expense	20,920		3,498,535	271
Interest income	(213)	(360)	(233)	(788)
TOTAL OTHER EXPENSE (INCOME)	(7,375,485)	(360)	(4,260,476)	(51,917)
NET INCOME (LOSS)	6,665,038	(500,510)	2,843,811	(940,381)
Deemed dividend			17,099,058	48,659
NET LOSS ATTRIBUTABLE TO COMPANY STOCKHOLDERS	$ 6,665,038	$ (500,510)	$ (14,255,247)	$ (989,040)
NET LOSS PER COMMON SHARE, BASIC	$ 1.29	$ (0.20)	$ (3.06)	$ (0.40)
NET LOSS PER COMMON SHARE, DILUTED	$ 1.29	$ (0.20)	$ (3.06)	$ (0.40)
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING, BASIC	5,183,724	2,520,429	4,661,183	2,497,457
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING, DILUTED	5,183,724	2,520,429	4,661,183	2,497,457